Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?-Reference-Cited by-同舟云学术

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Published:2008-11-30 Issue:18 Volume:22 Page:2481-2492
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference47 articles.

1. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study;Palella;J Acquir Immune Defic Syndr,2006

2. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers;Sabin;AIDS,2006

3. Mortality and progression to AIDS after starting highly active antiretroviral therapy;van Sighem;AIDS,2003

4. Initial treatment of HIV infection: randomized trials with clinical end points are still needed;Hughes;J Infect Dis,2006

5. Confounding by indication;Walker;Epidemiology,1996

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bovine models for human ovarian diseases;Progress in Molecular Biology and Translational Science;2022

2. Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania;BMC Pharmacology and Toxicology;2018-10-23

3. Modeling Outcomes of First-Line Antiretroviral Therapy and Rate of CD4 Counts Change among a Cohort of HIV/AIDS Patients in Ethiopia: A Retrospective Cohort Study;PLOS ONE;2016-12-20

4. Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort;Clinical Microbiology and Infection;2015-04

5. Dapagliflozin: A new sodium–glucose cotransporter 2 inhibitor for treatment of type 2 diabetes;American Journal of Health-System Pharmacy;2015-03-01